+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Specific and sensitive determination of pregnancy-specific beta1-glycoprotein by radioimmunoassay



Specific and sensitive determination of pregnancy-specific beta1-glycoprotein by radioimmunoassay



Obstetrical & Gynecological Survey 32(7): 578-579



A specific and highly sensitive radioimmunoassay (R.I.A.) for determination of pregnancy-specific beta 1-glycoprotein (S.P.1) in human plasma, urine, amniotic fluid, and breast milk has been developed. The minimum detection limit of S.P.1 was 8 mug/1 of sample. The assay was applied to plasma and/or urine samples from 8 women in early pregnancy. S.P. 1 was detected in the plasma of all three women obtained within 14 days of ovulation, the earliest positive result being at 7 days. In another woman plasma was negative at day 18 and positive by day 22. In the three remaining women plasma S.P.1 was detected when measured within 24 to 36 days of ovulation. S.P.1 was detected in four urine samples obtained between 20 and 28 days after ovulation. S.P.1 was also measured in breast milk, amniotic fluid, cord blood, and plasma of women with ectopic gestation and trophoblastic disease. It is suggested that the assay of S.P.1 may have important advantages over existing systems for detection and monitoring of early pregnancy.

(PDF emailed within 1 workday: $29.90)

Accession: 041405314

Download citation: RISBibTeXText

PMID: 904781


Related references

A simple and sensitive radioimmunoassay for pregnancy-specific beta1-glycoprotein. British Journal of Obstetrics and Gynaecology 84(8): 580-584, 1977

A radioimmunoassay of the pregnancy-specific beta1-glycoprotein (SP1). Scandinavian Journal of Clinical and Laboratory Investigation 37(6): 537-543, 1977

Multicomponent radioimmunoassay: simultaneous measurement of choriomammotropin and pregnancy-specific beta1-glycoprotein in pregnancy serum. Clinical Chemistry 27(10): 1744-16 +, 1981

Radioimmunoassay of SP1 (pregnancy-specific beta1-glycoprotein) in maternal blood and in amniotic fluid normal and pathologic pregnancies. Journal of Perinatal Medicine 9(2): 67-78, 1981

Non-specific serum/plasma response in radioimmunoassay of pregnancy-specific beta 1-glycoprotein (SP1) in healthy, non-pregnant subjects. Clinica Chimica Acta; International Journal of Clinical Chemistry 140(1): 101-108, 1984

Use of a rapid radioimmunoassay for pregnancy-specific beta-1 glycoprotein in gynecologic emergencies: comparison with routine urinary pregnancy test and a rapid radioimmunoassay for human chorionic gonadotropin. American Journal of Obstetrics and Gynecology 139(8): 968-970, 1981

Pregnancy specific beta1 glycoprotein (SP-1). Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl 8: 733-735, 2005

Plasma pregnancy-specific beta1-glycoprotein in complications of early pregnancy. British Journal of Obstetrics and Gynaecology 85(11): 832-836, 1978

Circulating levels of pregnancy-specific beta1-glycoprotein in early pregnancy. British Journal of Obstetrics and Gynaecology 84(10): 740-742, 1977

Plasma levels of pregnancy-specific beta1-glycoprotein in normal pregnancy. British Journal of Obstetrics and Gynaecology 83(10): 775-779, 1976

Two pregnancy-associated serum proteins with pregnancy-specific beta1-glycoprotein determinants. American Journal of Obstetrics and Gynecology 131(3): 262-266, 1978

Pregnancy-specific beta1-glycoprotein: a review. Obstetrical & Gynecological Survey 33(12): 761-768, 1978

Radioimmunoassay in estimating the concentration of pregnancy-specific beta-1-glycoprotein (SP-1) in normal pregnancy. Polski Tygodnik Lekarski 37(7): 181-184, 1982